Clinical-Stage Platforms
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 TMO | Thermo Fisher Scientific, Inc. | $178.3b | $485.07 | -1.3% | 470.8K |
 A | Agilent Technologies Inc. | $31.7b | $114.70 | -0.7% | 278.5K |
 WAT | Waters Corp | $28.8b | $303.39 | -0.3% | 128.0K |
 IQV | IQVIA Holdings Inc. | $27.9b | $168.67 | -2.6% | 353.1K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $19.9b | $47.69 | -1.8% | 261.6K |
 WST | West Pharmaceutical Services, Inc. | $17.7b | $254.38 | -0.2% | 96.6K |
 MEDP | Medpace Holdings, Inc. Common Stock | $13.1b | $491.85 | -1.3% | 85.2K |
 RVTY | Revvity, Inc. | $9.5b | $87.70 | -1.4% | 122.1K |
 TECH | Bio-Techne Corp. | $8.1b | $52.98 | -0.3% | 462.3K |
 QGEN | QIAGEN N.V. | $8.1b | $40.66 | -0.9% | 189.0K |
 ICLR | Icon Plc | $8.0b | $110.67 | -3.1% | 136.3K |
 CRL | Charles River Laboratories International, Inc. | $7.9b | $165.01 | -5.1% | 412.0K |
 BIO.B | Bio-Rad Laboratories, Inc. Class B | $7.5b | $281.08 | +1.0% | 13 |
 HALO | Halozyme Therapeutics, Inc. | $7.4b | $64.03 | -0.7% | 237.7K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $6.5b | $85.08 | -0.4% | 77.3K |
 RGEN | Repligen Corp | $6.3b | $116.83 | -0.8% | 111.7K |
 CGON | CG Oncology, Inc. Common stock | $5.4b | $67.65 | +0.3% | 179.8K |
 CELC | Celcuity Inc. Common Stock | $5.2b | $114.23 | +1.4% | 273.5K |
 BRKR | Bruker Corporation | $5.2b | $36.42 | -0.9% | 246.4K |
 AVTR | Avantor, Inc. | $5.1b | $7.86 | -0.5% | 1.4M |
 LGND | Ligand Pharmaceuticals Inc. | $3.8b | $204.39 | +2.4% | 75.4K |
 TWST | Twist Bioscience Corporation Common Stock | $2.7b | $51.33 | +2.2% | 164.3K |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.45 | +0.0% | 167.7K |
 MANE | Veradermics, Incorporated | $2.1b | $64.26 | +0.1% | 86.1K |
 KOD | Kodiak Sciences Inc Common Stock | $2.1b | $40.71 | +0.2% | 288.9K |
 TYRA | Tyra Biosciences, Inc. Common Stock | $1.9b | $39.65 | +0.1% | 317.5K |
 ZYME | Zymeworks Inc. | $1.8b | $26.20 | +1.6% | 102.1K |
 RLAY | Relay Therapeutics, Inc. Common Stock | $1.7b | $13.03 | +3.9% | 1.1M |
 NRIX | Nurix Therapeutics, Inc. Common stock | $1.5b | $16.62 | +7.1% | 680.5K |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $1.5b | $3.17 | +2.1% | 2.6M |
 OGN | Organon & Co. | $1.5b | $6.08 | -4.3% | 786.8K |
 GENB | Generate Biomedicines, Inc. Common Stock | $1.5b | $12.68 | -7.8% | 62.1K |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $1.4b | $12.50 | +4.7% | 427.3K |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $1.2b | $17.45 | +2.1% | 145.0K |
 HROW | Harrow, Inc. Common Stock | $1.2b | $35.50 | +0.5% | 93.4K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.2b | $21.29 | -0.9% | 76.7K |
 ALVO | Alvotech Ordinary Shares | $1.0b | $3.85 | +5.6% | 161.6K |
 ABCL | AbCellera Biologics Inc. Common Shares | $1.0b | $3.50 | -0.4% | 770.1K |
 PCRX | Pacira BioSciences, Inc. Common Stock | $0.9b | $22.49 | -0.9% | 76.9K |
 CMPX | Compass Therapeutics, Inc. Common Stock | $0.9b | $5.58 | +2.3% | 476.0K |
 CERT | Certara, Inc. Common Stock | $0.9b | $5.39 | -0.3% | 855.7K |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $0.9b | $65.38 | +2.9% | 41.0K |
 OPK | Opko Health Inc. | $0.8b | $1.19 | +3.9% | 1.3M |
 PHAT | Phathom Pharmaceuticals, Inc. Common Stock | $0.8b | $11.13 | -1.9% | 147.1K |
 FTRE | Fortrea Holdings Inc. Common Stock | $0.8b | $9.10 | -3.8% | 357.9K |
 SDGR | Schrodinger, Inc. Common Stock | $0.8b | $11.64 | +0.6% | 188.2K |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $0.7b | $4.63 | +12.2% | 2.9M |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.7b | $3.31 | +3.3% | 576.1K |
 ARVN | Arvinas, Inc | $0.7b | $11.28 | +3.9% | 424.7K |
 VOR | Vor Biopharma Inc. Common Stock | $0.6b | $16.95 | -6.1% | 423.0K |